Wen-Jye Lin, Ph.D.
Affiliations: | 2003 | University of Rochester, Rochester, NY |
Area:
Pathology, Molecular BiologyGoogle:
"Wen-Jye Lin"Mean distance: 10177.7
Parents
Sign in to add mentor| Chawnshang Chang | grad student | 2003 | Rochester | |
| (Molecular mechanisms of androgen receptor and nuclear orphan receptor TR4 in the disease processes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kano H, Izumi K, Hiratsuka K, et al. (2022) Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis. Cancer Science |
| Lin HP, Ho HM, Chang CW, et al. (2019) DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802558RR |
| Lin W, Chang C, Lin H, et al. (2019) Abstract B172: Molecular mechanisms of dual-specificity phosphatase 22 (DUSP22) in suppression of tumorigenesis: The potential involvement of the EGFR/PD-L1 axis Cancer Immunology Research. 7 |
| Natsagdorj A, Izumi K, Hiratsuka K, et al. (2018) CCL2 Induces Resistance to the Antiproliferative Effect of Cabazitaxel in Prostate Cancer Cells. Cancer Science |
| Chen MY, Hsu WC, Hsu SC, et al. (2018) PP4 deficiency leads to DNA replication stress that impairs immunoglobulin class switch efficiency. Cell Death and Differentiation |
| Urata S, Izumi K, Hiratsuka K, et al. (2017) CCL5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment. Cancer Science |
| Maolake A, Izumi K, Shigehara K, et al. (2016) Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis. Oncotarget |
| Izumi K, Mizokami A, Lin HP, et al. (2015) Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer. Oncotarget |
| Chan PC, Wu CY, Chou LS, et al. (2015) Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 394-402 |
| Lin W, Izumi K, Lin S, et al. (2015) Abstract B75: CCL2 promotes epithelial-mesenchymal transition (EMT) in prostate cancer cells via downregulation of dual-specificity phosphatase 22 Cancer Immunology Research. 3 |